Pd-1-pik

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePd-1-pik

Drug Alias NamePd-1-pik

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionProgrammed death-ligand 1 blockers

TargetsProgrammed death-ligand 1

Therapy Area/IndicationsGlioblastoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesHuashan Hospital Affiliated To Fudan University

China Registration ClassN/A

Develop Information

Active CompaniesHuashan Hospital Affiliated To Fudan University

Inactive CompaniesShanghai Cell Therapy Research Institute

Active IndicationsGlioblastoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A